In vitro, ex vivo and in vivo immunopharmacological acitivities of the isoxazoline compound VGX-1027: modulation of cytokine synthesis and prevention of both organ-specific and systemic autoimmune diseases in murine models

I. Stojanovic; S. Cuzzocrea; K. Mangano; E. Mazzon; D. Miljkovic; M. Wang; M. Donia; Y. Al Abed; Jiyoung Kim; F. Nicoletti; S. Stosic-Grujicic; M.H. Claesson

In vitro, ex vivo and in vivo immunopharmacological acitivities of the isoxazoline compound VGX-1027: modulation of cytokine synthesis and prevention of both organ-specific and systemic autoimmune diseases in murine models

I. Stojanovic, S. Cuzzocrea, K. Mangano, E. Mazzon, D. Miljkovic, M. Wang, M. Donia, Y. Al Abed, Jiyoung Kim, F. Nicoletti, S. Stosic-Grujicic, M.H. Claesson

46 Citations (Scopus)

Abstract

Udgivelsesdato: 2007

Original language	English
Journal	Clin Immunol
Volume	123
Issue number	3
Pages (from-to)	311-323
Number of pages	12
Publication status	Published - 2007

Cite this

Stojanovic, I., Cuzzocrea, S., Mangano, K., Mazzon, E., Miljkovic, D., Wang, M., Donia, M., Abed, Y. A., Kim, J., Nicoletti, F., Stosic-Grujicic, S., & Claesson, M. H. (2007). In vitro, ex vivo and in vivo immunopharmacological acitivities of the isoxazoline compound VGX-1027: modulation of cytokine synthesis and prevention of both organ-specific and systemic autoimmune diseases in murine models. Clin Immunol, 123(3), 311-323.

In vitro, ex vivo and in vivo immunopharmacological acitivities of the isoxazoline compound VGX-1027: modulation of cytokine synthesis and prevention of both organ-specific and systemic autoimmune diseases in murine models. / Stojanovic, I.; Cuzzocrea, S.; Mangano, K. et al.
In: Clin Immunol, Vol. 123, No. 3, 2007, p. 311-323.

Research output: Contribution to journal › Journal article › Research › peer-review

Stojanovic, I, Cuzzocrea, S, Mangano, K, Mazzon, E, Miljkovic, D, Wang, M, Donia, M, Abed, YA, Kim, J, Nicoletti, F, Stosic-Grujicic, S & Claesson, MH 2007, 'In vitro, ex vivo and in vivo immunopharmacological acitivities of the isoxazoline compound VGX-1027: modulation of cytokine synthesis and prevention of both organ-specific and systemic autoimmune diseases in murine models', Clin Immunol, vol. 123, no. 3, pp. 311-323.

@article{56afb7b020ec11ddbc23000ea68e967b,

title = "In vitro, ex vivo and in vivo immunopharmacological acitivities of the isoxazoline compound VGX-1027: modulation of cytokine synthesis and prevention of both organ-specific and systemic autoimmune diseases in murine models",

abstract = "Udgivelsesdato: 2007",

author = "I. Stojanovic and S. Cuzzocrea and K. Mangano and E. Mazzon and D. Miljkovic and M. Wang and M. Donia and Abed, {Y. Al} and Jiyoung Kim and F. Nicoletti and S. Stosic-Grujicic and M.H. Claesson",

year = "2007",

language = "English",

volume = "123",

pages = "311--323",

journal = "Clin Immunol",

issn = "1521-7035",

publisher = "Academic Press",

number = "3",

}

TY - JOUR

T1 - In vitro, ex vivo and in vivo immunopharmacological acitivities of the isoxazoline compound VGX-1027: modulation of cytokine synthesis and prevention of both organ-specific and systemic autoimmune diseases in murine models

AU - Stojanovic, I.

AU - Cuzzocrea, S.

AU - Mangano, K.

AU - Mazzon, E.

AU - Miljkovic, D.

AU - Wang, M.

AU - Donia, M.

AU - Abed, Y. Al

AU - Kim, Jiyoung

AU - Nicoletti, F.

AU - Stosic-Grujicic, S.

AU - Claesson, M.H.

PY - 2007

Y1 - 2007

N2 - Udgivelsesdato: 2007

AB - Udgivelsesdato: 2007

M3 - Journal article

SN - 1521-7035

VL - 123

SP - 311

EP - 323

JO - Clin Immunol

JF - Clin Immunol

IS - 3

ER -